PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
Shidong Lv(University of Pittsburgh), Chengyong Lei(Southern Medical University)
Cited by 121
Related Papers
Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer
|Journal of Clinical Investigation|2020|51
Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer
|Cell Death and Disease|2022|18
Integrated analysis reveals FOXA1 and Ku70/Ku80 as direct targets of ivermectin in prostate cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0